CoChat

Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

Ihl, Ralf, Bachinskaya, Natalia, Korczyn, Amos D., Vakhapova, Veronika, Tribanek, Michael, Hoerr, Robert, Napryeyenko, Oleksandr · 2011 · International Journal of Geriatric Psychiatry
Cited by 139

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: To test the efficacy and safety of a once‐daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. Methods: Multi‐centre trial of 410 outpatients with mild to moderate dementia (Alzheimer's disease, vascular dementia or mixed form) scoring between 9 and 23 on the SKT cognitive test battery, at least five on the Neuropsychiatric Inventory (NPI) and three or higher in at least one item of the NPI. Patients were randomly allocated to double‐blind treatment with 240 mg of EGb 761 or placebo once daily for 24 weeks. Primary outcomes were the changes from baseline in the SKT total score and the NPI total score. The Alzheimer's Disease Cooperative Study Clinical Global Impression of Change (ADCS‐CGIC), Activities of Daily Living International Scale (ADL‐IS), NPI distress score, DEMQOL‐Proxy quality‐of‐life scale and Verbal Fluency Test were secondary outcomes. Results: At endpoint, patients treated with EGb 761 (n = 202) improved by −1.4 (95% confidence interval −1.8; −1.0) points on the SKT and by −3.2 (−4.0; −2.3) on the NPI total score, whereas those receiving placebo (n = 202) deteriorated by +0.3 (−0.1; 0.7) on the SKT and did not change on the NPI total score (−0.9; 0.9). Both drug‐placebo comparisons were significant at p < 0.001. EGb 761 was significantly superior to placebo with respect to all secondary outcome measures. Adverse event rates were similar for both treatment groups. Conclusions: EGb 761, 240 mg once‐daily, was found significantly superior to placebo in the treatment of patients with dementia with neuropsychiatric symptoms. Copyright © 2010 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gps.2662

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 139

Metadata

Authors
Ihl, R., Bachinskaya, N., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O.
Venue
International Journal of Geriatric Psychiatry
Publisher
Wiley
Published
2010-12-07
Volume
26
Issue
11
Pages
1186-1194
ISSN
  • 0885-6230 (ISSN-L)
  • 1099-1166
OpenAlex
W2033307745
Cited by
139
References
8
FWCI
22.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. https://app.cochat.ai/papers/10.1002/gps.2662
The paper
Ihl, R., Bachinskaya, N., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O. (2011). Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.